$46.97
0.761.64%
Últ. Act.: Oct 2, 4:00 PM
$46.97
0.761.64%
Enliven Therapeutics (ELVN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.42 | $-0.45 | $-0.45 |
| Actual | $-0.49 | $-0.38 | $-0.48 | $-0.32 |
| Surprise | -32.4% | +9.52% | -6.67% | +28.9% |
| Revenue | ||||
| Estimate | — | $10000 | $10000 | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | -100.0% | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.44 | $-0.58 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.49 | $-0.37 | -32.4 % |
| Q1 | May 7, 2026 | $-0.38 | $-0.42 | 9.52 % |
| Q4 | Mar 3, 2026 | $-0.48 | $-0.45 | -6.67 % |
| Q3 | Nov 12, 2025 | $-0.32 | $-0.45 | 28.9 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 7, 2026 | $0 | $10.00K | -100.0 % |
| Q4 | Mar 3, 2026 | $0 | $10.00K | -100.0 % |